McConnell Pressures FDA to Craft CBD Rules

4y
3m read
Summary

More on Cannabis To stay informed on the latest reports on cannabis policy, cannabis business, or cannabis research studies, visit our news page. The hemp and CBD industry remains largely unregulated, however, with consumers unsure of the quality of many CBD products. McConnell continues to champion the nation’s hemp industry, this time by urging the FDA to more quickly take action. Several lawmakers have urged federal agencies to more quickly clarify CBD regulations. FDA announced in July that it would expedite its work to address rules and regulations on CBD and would release a progress report by early fall.

Article Preview

McConnell continues to champion the nation’s hemp industry, this time by urging the FDA to more quickly take action.

The senator who played a pivotal role in the effort to federally legalize hemp and its derivatives is now putting pressure on the Food and Drug Administration (FDA) to expedite its crafting of the rules and regulations on hemp-derived cannabidiol (CBD) products.

Senate Majority Leader Mitch McConnell (R-KY) this week introduced language that would require the FDA to issue temporary...

Read the full article @ Medical Marijuana Inc